Wegener 	Wegener 	 NNP	O
's  	's  	 POS	O
granulomatosis  	granulomatosis  	 FW	B-NP
occurring  	occurring  	 FW	I-NP
de  	de  	 FW	I-NP
novo  	novo  	 FW	I-NP
during  	during  	 FW	O
pregnancy  	pregnancy  	 FW	O
Wegener 	Wegener 	 NNP	O
's  	's  	 POS	O
granulomatosis  	granulomatosis  	 NN	B-NP
( 	( 	 -LRB-	O
WG 	WG 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
rarely  	rarely  	 RB	O
diagnosed  	diagnosed  	 VBN	O
during  	during  	 IN	O
the  	the  	 DT	O
reproductive  	reproductive  	 JJ	B-NP
years  	years  	 NNS	I-NP
and  	and  	 CC	O
uncommonly  	uncommonly  	 JJ	O
manifests  	manifests  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
time  	time  	 NN	O
during  	during  	 IN	O
pregnancy 	pregnancy 	 NN	O
.  	.  	 .	O
We  	We  	 PRP	O
report  	report  	 VBP	O
a  	a  	 DT	O
case  	case  	 NN	O
of  	of  	 IN	O
de  	de  	 FW	B-NP
novo  	novo  	 FW	I-NP
WG  	WG  	 FW	I-NP
presenting  	presenting  	 FW	O
at  	at  	 IN	O
30  	30  	 CD	O
weeks  	weeks  	 NNS	O
gestation  	gestation  	 VBN	B-NP
with  	with  	 IN	O
classical  	classical  	 JJ	B-NP
symptoms  	symptoms  	 NNS	I-NP
of  	of  	 IN	I-NP
WG  	WG  	 NNP	I-NP
( 	( 	 -LRB-	O
ENT 	ENT 	 NNP	B-NP
,  	,  	 ,	O
pulmonary 	pulmonary 	 CD	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
diagnosis  	diagnosis  	 NN	O
was  	was  	 VBD	O
confirmed  	confirmed  	 VBN	O
by  	by  	 IN	O
radiological 	radiological 	 NN	B-NP
,  	,  	 ,	O
laboratory 	laboratory 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
histological  	histological  	 JJ	B-NP
investigations 	investigations 	 NNS	I-NP
.  	.  	 .	O
With  	With  	 IN	O
a  	a  	 DT	O
multidisciplinary  	multidisciplinary  	 JJ	B-NP
approach 	approach 	 NN	I-NP
,  	,  	 ,	O
she  	she  	 PRP	O
had  	had  	 VBD	O
a  	a  	 DT	O
successful  	successful  	 JJ	O
vaginal  	vaginal  	 JJ	B-NP
delivery  	delivery  	 NN	I-NP
of  	of  	 IN	O
a  	a  	 DT	O
healthy  	healthy  	 JJ	O
baby 	baby 	 NN	O
.  	.  	 .	O
She  	She  	 PRP	O
was  	was  	 VBD	O
treated  	treated  	 VBN	O
successfully  	successfully  	 RB	O
by  	by  	 IN	O
a  	a  	 DT	O
combination  	combination  	 NN	O
of  	of  	 IN	O
steroids 	steroids 	 NNS	O
,  	,  	 ,	O
azathioprine  	azathioprine  	 NN	B-NP
and  	and  	 CC	O
intravenous  	intravenous  	 JJ	B-NP
immunoglobulin  	immunoglobulin  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
active  	active  	 JJ	O
phase  	phase  	 NN	O
of  	of  	 IN	O
disease  	disease  	 NN	O
for  	for  	 IN	O
induction  	induction  	 NN	B-NP
of  	of  	 IN	O
remission  	remission  	 NN	O
and  	and  	 CC	O
by  	by  	 IN	O
azathioprine  	azathioprine  	 NN	B-NP
and  	and  	 CC	O
steroids  	steroids  	 NNS	O
for  	for  	 IN	O
maintenance  	maintenance  	 NN	O
of  	of  	 IN	O
remission 	remission 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
significant  	significant  	 JJ	O
improvement  	improvement  	 NN	O
in  	in  	 IN	O
her  	her  	 PRP$	O
symptoms  	symptoms  	 NNS	B-NP
allowed  	allowed  	 VBD	O
us  	us  	 PRP	O
to  	to  	 TO	O
continue  	continue  	 VB	O
her  	her  	 PRP$	O
pregnancy  	pregnancy  	 NN	O
to  	to  	 TO	O
37  	37  	 CD	O
weeks  	weeks  	 NNS	O
when  	when  	 WRB	O
delivery  	delivery  	 NN	O
was  	was  	 VBD	O
electively  	electively  	 JJ	B-NP
induced 	induced 	 NN	I-NP
.  	.  	 .	O
Transplacental  	Transplacental  	 JJ	B-NP
transmission  	transmission  	 NN	I-NP
of  	of  	 IN	I-NP
PR3-ANCA  	PR3-ANCA  	 NNP	I-NP
occurred  	occurred  	 VBD	O
but  	but  	 CC	O
the  	the  	 DT	O
neonate  	neonate  	 NN	B-NP
remained  	remained  	 VBD	O
well 	well 	 RB	O
.  	.  	 .	O
This  	This  	 DT	O
case  	case  	 NN	O
of  	of  	 IN	O
de  	de  	 FW	B-NP
novo  	novo  	 FW	I-NP
WG  	WG  	 NNP	I-NP
during  	during  	 IN	O
pregnancy  	pregnancy  	 NN	O
highlights  	highlights  	 VBZ	O
the  	the  	 DT	O
seriousness  	seriousness  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
disease  	disease  	 NN	O
and  	and  	 CC	O
the  	the  	 DT	O
challenge  	challenge  	 NN	O
in  	in  	 IN	O
management  	management  	 NN	O
of  	of  	 IN	O
such  	such  	 JJ	O
patients 	patients 	 NNS	O
.  	.  	 .	O
